Tips for extended telehealth consultations for medicines reviews

In response to the COVID-19 pandemic, pharmacists may continue delivering medicine reviews via telehealth until 31 March 2021.

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

TGA outcomes of listed sunscreen products review

Pharmacists may recall news headlines earlier this year about people experiencing significant sunburn despite application of high sun protection factor sunscreens. Reports were accompanied...

2019 year in review

It was a big year for Australian pharmacists, with the release of important reports calling for reform for the profession and providing a vision...

TGA changes continue to impact and sometimes baffle pharmacists

A number of recent decisions by the Therapeutic Goods Administration (TGA) are highly relevant to pharmacists in Australia. Firstly, the interim decision from the...

Pharmacists can have a big impact on men’s mental health

A recent report released by Beyond Blue has further revealed the state of men’s mental health in Australia. Pharmacists can help to intervene before...